|
FGD6 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.71270000000657E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.375370E-03 |
| Normal-vs-Stage2 |
1.918350E-03 |
| Normal-vs-Stage3 |
1.817510E-04 |
| Normal-vs-Stage4 |
1.23829999998382E-06 |
| Stage1-vs-Stage2 |
2.904000E-01 |
| Stage1-vs-Stage3 |
2.007600E-01 |
| Stage1-vs-Stage4 |
5.024400E-03 |
| Stage2-vs-Stage3 |
9.073200E-01 |
| Stage2-vs-Stage4 |
1.852400E-01 |
| Stage3-vs-Stage4 |
8.481800E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.89880000000576E-05 |
| Normal-vs-AfricanAmerican |
2.231000E-01 |
| Normal-vs-Asian |
8.725900E-02 |
| Caucasian-vs-AfricanAmerican |
1.714820E-01 |
| Caucasian-vs-Asian |
1.765390E-01 |
| AfricanAmerican-vs-Asian |
8.037200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.10360000000898E-05 |
| Normal-vs-Female |
2.393900E-04 |
| Male-vs-Female |
4.368800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.427900E-04 |
| Normal-vs-Age(41-60Yrs) |
8.607400E-04 |
| Normal-vs-Age(61-80Yrs) |
2.13089999999694E-05 |
| Normal-vs-Age(81-100Yrs) |
2.272200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.294600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.875800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.448600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.728210E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.516200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.832600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.261400E-01 |
| Classical-VS-Follicular |
8.957000E-01 |
| Classical-VS-Other |
2.078400E-01 |
| Classical-VS-Normal |
3.178000E-04 |
| Tall-VS-Follicular |
4.869800E-01 |
| Tall-VS-Other |
4.103800E-01 |
| Tall-VS-Normal |
4.035000E-03 |
| Follicular-VS-Other |
2.867800E-01 |
| Follicular-VS-Normal |
1.004210E-02 |
| Other-VS-Normal |
1.580230E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.043700E-04 |
| Normal-vs-N1 |
3.665900000005E-05 |
| N0-vs-N1 |
1.867180E-01 |
|
|
